GROWTH-INHIBITION OF LEUKEMIA L-1210 ASCITES TUMOR BY COMBINATION OF CARRAGEENAN AND MITOMYCIN-C INVIVO

被引：0

|

作者：

MATSUMOTO, T

TAGUCHI, A

OKAWA, Y

MIKAMI, T

SUZUKI, K

SUZUKI, S

SUZUKI, M

机构：

来源：

JOURNAL OF PHARMACOBIO-DYNAMICS | 1984年 / 7卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：465 / 471

页数：7

相关论文

共 41 条

[31] GROWTH-INHIBITION OF MOUSE LEUKEMIA-L1210 CELLS WITH METHYLGLYOXAL-BIS(GUANYLHYDRAZONE) (MGBG) - POSSIBLE RELATIONSHIP WITH ANTI-MITOCHONDRIAL DRUG ACTION
PATHAK, SN
PORTER, CW
DAVE, C
[J]. FEDERATION PROCEEDINGS, 1977, 36 (03) : 281 - 281
[32] INHIBITION BY HYDRAZINE SULFATE AND VARIOUS HYDRAZIDES, OF IN-VIVO GROWTH OF WALKER 256 INTRAMUSCULAR CARCINOMA, B-16 MELANOMA, MURPHY-STURM LYMPHOSARCOMA AND L-1210 SOLID LEUKEMIA
GOLD, J
[J]. ONCOLOGY, 1973, 27 (01) : 69 - 80
[33] THYMIDINE-14C AND -3H DOUBLE-LABELING TECHNIC IN STUDY OF CELL CYCLE OF L1210 LEUKEMIA ASCITES TUMOR IN VIVO
YOUNG, RC
DEVITA, VT
PERRY, S
[J]. CANCER RESEARCH, 1969, 29 (08) : 1581 - &
[34] IN-VIVO GROWTH-INHIBITION OF L1210 LEUKEMIA BY 4-AMIDINOINDAN-1-ONE 2'-AMIDINOHYDRAZONE (CGP 48664A), A NEW INHIBITOR OF S-ADENOSYLMETHIONINE DECARBOXYLASE
DORHOUT, B
VELDE, RJT
FERWERDA, H
KINGMA, AW
DEHOOG, E
MUSKIET, FAJ
[J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (02) : 214 - 217
[35] ANTITUMOR-ACTIVITY OF A DERIVATIVE OF MITOMYCIN, 7-N-[2-[[2-(GAMMA-L-GLUTAMYLAMINO)ETHYL]DITHIO]ETHYL]MITOMYCIN-C (KW-2149), AGAINST MURINE AND HUMAN TUMORS AND A MITOMYCIN-C-RESISTANT TUMOR INVITRO AND INVIVO
TSURUO, T
SUDO, Y
ASAMI, N
INABA, M
MORIMOTO, M
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 27 (02) : 89 - 93
[36] TRANSPORT, GROWTH-INHIBITION AND BIOCHEMICAL PROPERTIES OF GAMMA-GLUTAMYL AND GAMMA-ASPARTYL PEPTIDES OF 2,4-DIAMINO FOLATE ANALOGS IN L1210 LEUKEMIA-CELLS INVITRO
SIROTNAK, FM
CHELLO, PL
PIPER, JR
MONTGOMERY, JA
[J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 113 - 113
[37] COMBINATION CHEMOTHERAPY AGAINST L1210 AND P388 LEUKEMIA - MELPHALAN-5-FLUOROURACIL, VINCRISTINE-ADRIAMYCIN, MECHLORETHAMINE-HYDROXY-UREA, AND METHOTREXATE-MITOMYCIN C
MABEL, JA
MERKER, PC
WODINSKY, I
GERAN, RI
[J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 144 - 144
[38] INTRAARTERIAL INFUSION OF DIBUTYRYL CYCLIC ADENOSINE-MONOPHOSPHATE PLUS MITOMYCIN-C FOR UNRESECTABLE HEPATOCELLULAR-CARCINOMA - LONG-TERM SURVIVAL AND RESPONSE TO TUMOR-GROWTH INHIBITION
KUSANO, S
KATAYAMA, M
UEMATSU, M
KAJI, T
KOSUDA, S
ENDO, T
SUGIMOTO, M
ISHII, K
[J]. ACADEMIC RADIOLOGY, 1995, 2 (04) : 286 - 292
[39] BIOCHEMICAL AND ANTI-TUMOR ACTIVITY ASSOCIATED WITH THE EXPOSURE OF LEUKEMIA-L1210 CELLS TO THE COMBINATION OF THYMIDINE (TDR) AND 1-BETA-D-ARABINOFURANOSYL CYTOSINE (ARA-C)
KINAHAN, JJ
KOWAL, EP
[J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 278 - 278
[40] Pharmacology of Combination Chemotherapy of Cytosine Arabinoside (Ara-C) and Uracil Arabinoside (Ara-U) or Tetrahydrouridine (THU) against Murine Leukemia L1210/0 in Tumor-Bearing Mice
Avramis, Vassilios I.
Powell, William
[J]. CANCER INVESTIGATION, 1987, 5 (04) : 293 - 299

← 1 2 3 4 5 →